Author:
Memon Bilal Mustafa,Khoso Saleem Ahmed,Ateya Abeer Ali El-Sherbiny,Eltayeb Lienda Bashier
Reference20 articles.
1. Ahlawat, R., D'Cruz, S., & Tiwari, P. (2015). Drug utilization pattern in chronic kidney disease patients at a tertiary care public teaching hospital: Evidence from a cross-sectional study. Journal of Pharmaceutical Care & Health Systems, 3, 2376-2419.
2. Alqurashi, M. Y., Alharthi, K. F., Abdulrahman, A., Alshehri, Y. K. A., Sanousi, M. A., Abdullah, A., Almazyed, K. S. A., Alrashidi, S. M., Abdullah, W., Qaeed, A. A. A., et al. (2021). The Role of Dpp-4 Inhibitors In Type-2 Diabetes Patients With Chronic Kidney Disease. Pharmacophore, 12(3), 91-94.
3. Al-Ramahi R. (2012). Medication prescribing patterns among chronic kidney disease patients in a hospital in Malaysia. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 23(2), 403-408.
4. Bajait, C. S., Pimpalkhute, S. A., Sontakke, S. D., Jaiswal, K. M., & Dawri, A. V. (2014). Prescribing pattern of medicines in chronic kidney disease with emphasis on phosphate binders. Indian Journal of Pharmacology, 46(1), 35-39. doi:10.4103/0253-7613.125163
5. Castelino, R. L., Saunder, T., Kitsos, A., Peterson, G. M., Jose, M., Wimmer, B., Khanam, M., Bezabhe, W., Stankovich, J., & Radford, J. (2020). Quality use of medicines in patients with chronic kidney disease. BMC Nephrology, 21(1), 216. doi:10.1186/s12882-020-01862-1